Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 9707-9717

  Banerjee, Prabal ^a   Feuer, Gerold ^a   Barker, Edward ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; 2B4 PROTEIN, HUMAN; CD150 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; ICAM2 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; NATURAL KILLER CELL ACTIVATING RECEPTORS; ONCOPROTEIN; P12I PROTEIN, HUMAN T LYMPHOTROPIC VIRUS 1; P12I PROTEIN, HUMAN T-LYMPHOTROPIC VIRUS 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL LINE; CELLULAR IMMUNITY; CLINICAL TRIAL; COCULTURE; DOWN REGULATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE; COCULTURE TECHNIQUES; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, CELLULAR; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIGANDS; MEMBRANE GLYCOPROTEINS; ONCOGENE PROTEINS, VIRAL; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TRANSCRIPTION FACTORS;

EID: 35348825570     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00887-07     Document Type: Article

References (77)

1. I is required for efficient viral infectivity in primary lymphocytes. J. Virol. 74:9828-9835.
2. Arnon, T. I., M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680-2689.
3. Bangham, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24:6035-6046.
4. Barber, D. F., M. Faure, and E. O. Long. 2004. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173:3653-3659.
5. Barber, D. F., and E. O. Long. 2003. Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J. Immunol. 170:294-299.
6. Biagi, E., F. Bambacioni, G. Gaipa, C. Casati, J. Golay, A. Biondi, and M. Introna. 2001. Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells. Hematologica 86:13-16.
7. Biassoni, R., C. Cantoni, M. Falco, D. Pende, R. Millo, L. Moretta, C. Bottino, and A. Moretta. 2000. Human natural killer cell activating receptors. Mol. Immunol. 37:1015-1024.
8. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
9. Bonaparte, M. I., and E. Barker. 2004. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104:2087-2094.
10. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, M. Vitale, L. Moretta, M. Lopez, and A. Moretta. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198:557-567.
11. Boyum, A. 1968. Separation of leukocytes from blood and bone marrow: introduction. Scand. J. Clin. Lab. Investig. Suppl. 97:7.
12. Brutkiewicz, R. R., and R. M. Welsh. 1995. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69:3967-3971.
13. Bryceson, Y. T., M. E. March, D. F. Barber, H. G. Ljunggren, and E. O. Long. 2005. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202:1001-1012.
14. Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40-52.
15. Burshtyn, D. N., A. S. Lam, M. Weston, N. Gupta, P. A. Warmerdam, and E. O. Long. 1999. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J. Immunol. 162:897-902.
16. Burshtyn, D. N., J. Shin, C. Stebbins, and E. O. Long. 2000. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr. Biol. 10:777-780.
17. Carman, C. V., and T. A. Springer. 2003. Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15:547-556.
18. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41-49.
19. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
20. Chisholm, S. E., and H. T. Reyburn. 2006. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 80:2225-2233.
21. Collins, N. D., G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner, and M. D. Lairmore. 1998. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91:4701-4707.
22. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809-1818.
23. I expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 76:10374-10382.
24. Ding, W., S. J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore. 2003. Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J. Virol. 77:11027-11039.
25. Falco, M., E. Marcenaro, E. Romeo, F. Bellora, D. Marras, F. Vely, G. Ferracci, L. Moretta, A. Moretta, and C. Bottino. 2004. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34: 1663-1672.
26. Feuer, G., S. A. Stewart, S. M. Baird, F. Lee, R. Feuer, and I. S. Chen. 1995. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69:1328-1333.
27. Fruh, K., A. Gruhler, R. M. Krishna, and G. J. Schoenhals. 1999. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway. Immunol. Rev. 168:157-166.
28. Fukudome, K., M. Furuse, N. Fukuhara, S. Orita, T. Imai, S. Takagi, M. Nagira, Y. Hinuma, and O. Yoshie. 1992. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int. J. Cancer 52:418-427.
29. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186-1190.
30. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
31. Gregory, C. D., R. J. Murray, C. F. Edwards, and A. B. Rickinson. 1988. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T-cell surveillance. J. Exp. Med. 167:1811-1824.
32. Hayflick, J. S., J. Stine, R. Fox, D. Hoekstra, and W. M. Gallatin. 1997. Functional mapping of the cytoplasmic region of intercellular adhesion molecule-3 reveals important roles for serine residues. J. Biol. Chem. 272:22207-22214.
33. Helander, T. S., and T. Timonen. 1998. Adhesion in NK cell function. Curr. Top. Microbiol. Immunol. 230:89-99.
34. Hildreth, J. E., F. M. Gotch, P. D. Hildreth, and A. J. McMichael. 1983. A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur. J. Immunol. 13:202-208.
35. Hodge, D. L., W. B. Schill, J. M. Wang, I. Blanca, D. A. Reynolds, J. R. Ortaldo, and H. A. Young. 2002. IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J. Immunol. 168:6090-6098.
36. Ishido, S., J. K. Choi, B. S. Lee, C. Wang, M. DeMaria, R. P. Johnson, G. B. Cohen, and J. U. Jung. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13:365-374.
37. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Down-regulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:5300-5309.
38. I protein. J. Virol. 75:6086-6094.
39. Kim, S. J., A. M. Nair, S. Fernandez, L. Mathes, and M. D. Lairmore. 2006. Enhancement of LFA-1-mediated T-cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 176:5463-5470.
40. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
41. Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol. 68:1854-1863.
42. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1759.
43. MacFarlane, A. W. T., and K. S. Campbell. 2006. Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 298:23-57.
44. Marriott, S. J., F. J. Lemoine, and K. T. Jeang. 2002. Damaged DNA and miscounted chromosomes: human T-cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. J. Biomed. Sci. 9:292-298.
45. Matsumoto, G., M. P. Nghiem, N. Nozaki, R. Schmits, and J. M. Penninger. 1998. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J. Immunol. 160:5781-5789.
46. Matsumoto, G., Y. Omi, U. Lee, T. Nishimura, J. Shindo, and J. M. Penninger. 2000. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity. Eur. J. Immunol. 30:3723-3731.
47. Messmer, B., P. Eissmann, S. Stark, and C. Watzl. 2006. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J. Immunol. 176:4646-4650.
48. Moretta, A., R. Biassoni, C. Bottino, M. C. Mingari, and L. Moretta. 2000. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today 21:228-234.
49. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
50. Moretta, L., and A. Moretta. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23:255-259.
51. Mulloy, J. C., R. W. Crownley, J. Fullen, W. J. Leonard, and G. Franchini. 1996. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gamma chains and affects their expression on the cell surface. J. Virol. 70:3599-3605.
52. Nair, A., B. Michael, H. Hiraragi, S. Fernandez, G. Feuer, K. Boris-Lawrie, and M. Lairmore. 2005. Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res. Hum. Retrovir. 21: 273-284.
53. I. Virology 353:247-257.
54. Nicot, C., R. L. Harrod, V. Ciminale, and G. Franchini. 2005. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene 24:6026-6034.
55. Ohashi, I., S. Hanabuchi, R. Suzuki, H. Kato, T. Masuda, and M. Kannagi. 2002. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model. J. Virol. 76:7010-7019.
56. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-1 associated myelopathy, a new clinical entity, Lancet i.1031-1032.
57. Owen, S. M., D. L. Rudolph, C. S. Dezzutti, N. Shibata, S. Naik, S. W. Caughman, and R. B. Lai. 1997. Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element. AIDS Res. Hum. Retrovir. 13:1429-1437.
58. Parker, C. E., S. Daenke, S. Nightingale, and C. R. Bangham. 1992. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188:628-636.
59. Pende, D., C. Cantoni, P. Rivera, M. Vitale, R. Castriconi, S. Marcenaro, M. Nanni, R. Biassoni, C. Bottino, A. Moretta, and L. Moretta. 2001. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of non-epithelial origin. Eur. J. Immunol. 31:1076-1086.
60. Pende, D., G. M. Spaggiari, S. Marcenaro, S. Martini, P. Rivera, A. Capobianco, M. Falco, E. Lanino, I. Pierri, R. Zambello, A. Bacigalupo, M. C. Mingari, A. Moretta, and L. Moretta. 2005. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 105: 2066-2073.
61. + natural killer cells. Blood 104:1083-1093.
62. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
63. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:5682-5687.
64. Ruscetti, F. W., J. A. Mikovits, V. S. Kalyanaraman, R. Overton, H. Stevenson, K. Stromberg, R. B. Herberman, W. L. Farrar, and J. R. Ortaldo. 1986. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J. Immunol. 136:3619-3624.
65. Sawada, M., A. Suzumura, M. Yoshida, and T. Marunouchi. 1990. Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells. J. Virol. 64:4002-4006.
66. Sieburg, M., A. Tripp, J. W. Ma, and G. Feuer. 2004. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J. Virol. 78:10399-10409.
67. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29:1656-1666.
68. Sonoda, S., S. Yashiki, K. Takahashi, N. Arima, Y. Daitoku, M. Matsumoto, T. Matsumoto, M. Tara, K. Shinmyozu, K. Sato, et al. 1987. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int. J. Cancer 40:629-634.
69. Stewart, S. A., G. Feuer, A. Jewett, F. V. Lee, B. Bonavida, and I. S. Chen. 1996. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice. Virology 226:167-175.
70. Tanaka, Y., M. Hayashi, S. Takagi, and O. Yoshie. 1996. Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses. J. Virol. 70:8508-8517.
71. kip1 expression. J. Virol. 79:14069-14078.
72. + cells in vitro. J. Virol. 77:12152-12164.
73. Uno, H., H. Matsuoka, M. Suzuki, K. Tsuda, and H. Tsubouchi. 1995. Altered expression of class I HLA antigen on peripheral mononuclear cells in patients with adult T-cell leukemia: inverse relationship with natural killer susceptibility. Cancer Epidemiol. Biomarkers Prev. 4:367-372.
74. van Kooyk, Y., and C. G. Figdor. 2000. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr. Opin. Cell Biol. 12:542-547.
75. + T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. USA 102:10981-10986.
76. Wang, J., and T. A. Springer. 1998. Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol. Rev. 163:197-215.
77. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.